We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
140 hedge funds and large institutions have $756M invested in Alder Biopharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
81% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 32
42% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 19
6% more funds holding
Funds holding: 132 → 140 (+8)
6% less capital invested
Capital invested by funds: $803M → $756M (-$47.3M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
31% less call options, than puts
Call options by funds: $799K | Put options by funds: $1.17M
Holders
140
Holders Change
+8
Holders Change %
+6.06%
% of All Funds
3.18%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
27
Increased
58
Reduced
32
Closed
19
Calls
$799K
Puts
$1.17M
Net Calls
-$367K
Net Calls Change
+$165K
Top Buyers
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$19.8M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.53M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.15M |
| 4 |
Morgan Stanley
New York
|
+$4.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.72M |
